Low Dose Teclistamab in Newly Diagnosed Multiple Myeloma Patients

Clinical trial NCT06758375 · RECRUITING

Trial details

NCT number: NCT06758375
Sponsor: Hospital Universitario Dr. Jose E. Gonzalez
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma, Newly Diagnosed

Start date: 2025-03-03
Primary completion: 2026-09-07
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.